Document Library

Click the icons below to search through Pioneer’s reports and documents.

Filename Icer-Onc-WP-3.pdf
Filesize 1 MB
Version 1 Previous versions
Date added April 6, 2021
Downloaded 752 times
Category Health Care, Life Sciences, White Papers

Author: William Smith

Date: April 6, 2021

This report examines the alarming methodological and contextual shortcomings of the Quality Adjusted Life Years (QALY)-based methodology in evaluating new cancer therapies. It reveals five specific problems with ICER’s evaluation of cancer treatments and demonstrates the urgent need to prohibit the use of the QALY amid trends in rapid cancer innovations and personalized medicine.